{"id":23537,"date":"2022-01-07T11:58:22","date_gmt":"2022-01-07T16:58:22","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=23537"},"modified":"2022-01-07T11:58:22","modified_gmt":"2022-01-07T16:58:22","slug":"ipo-pipeline-update-new-filings-week-ending-1-7-22","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-new-filings-week-ending-1-7-22\/","title":{"rendered":"IPO Pipeline Update: New Filings week ending 1.7.22"},"content":{"rendered":"
NEW FILINGS<\/u>
\n<\/b><\/div>\n
\n<\/b><\/div>\n

Company: Affinia Therapeutics Inc.<\/p>\n

Symbol: AFTX (Nasdaq)<\/p>\n

Description:\u00a0 They are a preclinical stage company pioneering a new class of rationally designed gene therapies with potentially curative benefit in patients with both rare and prevalent devastating diseases.<\/p>\n

Shares: TBD<\/p>\n

Price Range: TBD<\/p>\n

Trade Date:\u00a0 TBD<\/p>\n

Underwriters: Goldman Sachs, Jefferies, Piper Sandler<\/p>\n

Co-Manager(s): Chardan<\/p>\n

Link to Prospectus: Filed: 1-4-22<\/a><\/p>\n

Listed Cash Raise: $100m<\/p>\n

 <\/p>\n

<\/p>\n

 <\/p>\n

Company: Specialty Building Products, Inc.<\/p>\n

Symbol: SBP (Nasdaq)<\/p>\n

Description:\u00a0 They believe they are the largest and fastest growing distributor of branded specialty building products in the United States.<\/p>\n

Shares: TBD<\/p>\n

Price Range: TBD<\/p>\n

Trade Date:\u00a0 TBD<\/p>\n

Underwriters: Barclays, Goldman Sachs, RBC Capital Markets (alphabetical)<\/p>\n

Co-Manager(s): BofA Securities, Jefferies, Baird, Raymond James, Truist Securities, Wolfe Nomura Alliance<\/p>\n

Link to Prospectus: Filed: 1-4-22<\/a><\/p>\n

Listed Cash Raise: $100m<\/p>\n

\n<\/p>\n

 <\/p>\n

Company: Credo Technology Group Holding Ltd<\/p>\n

Symbol: CRDO (Nasdaq)<\/p>\n

Description:\u00a0 Credo is an innovator in providing secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data generation and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market.<\/p>\n

Shares: TBD<\/p>\n

Price Range: TBD<\/p>\n

Trade Date:\u00a0 TBD<\/p>\n

Underwriters: Goldman Sachs, BofA Securities, Cowen, Mizuho Securities, Needham & Company, Stifel<\/p>\n

Co-Manager(s): Craig-Hallum, Roth Capital<\/p>\n

Link to Prospectus: Filed: 1-3-22<\/a><\/p>\n

Listed Cash Raise: $100m<\/p>\n

 <\/p>\n

<\/p>\n

<\/div>\n
TERMS ADDED
\n<\/u><\/b><\/div>\n
<\/div>\n
<\/u><\/b><\/p>\n

Company: TPG Inc.<\/p>\n

Symbol: TPG (Nasdaq)<\/p>\n

Description: They are a leading global alternative asset manager with approximately $109 billion in assets under management as of September 30, 2021.<\/p>\n

Shares: 33.9 million<\/p>\n

Price Range: $28.00-$31.00<\/p>\n

Market Cap: $8.6b-$9.5b<\/p>\n

Trade Date:\u00a0 Thursday, 1\/13<\/p>\n

Underwriters: J.P. Morgan, Goldman Sachs, Morgan Stanley, TPG Capital, BofA Securities, Citigroup, Deutsche Bank Securities, Evercore ISI, UBS Investment Bank, Wells Fargo Securities, BMO Capital Markets, Barclays<\/p>\n

Co-Manager(s): Mizuho Securities, Keefe Bruyette & Woods, MUFG, SMBC Nikko, AmeriVet Securities, Blaylock Van, C.L. King & Associates, Drexel Hamilton, R. Seelaus & Co., Ramirez & Co., Siebert Williams Shank<\/p>\n

Link to Prospectus: Terms Added: 1-4-22<\/a><\/p>\n

<\/p>\n

Company: Justworks, Inc.<\/p>\n

Symbol: JW (Nasdaq)<\/p>\n

Description: Justworks is a cloud-based software platform that gives small and medium-sized businesses (\u201cSMBs\u201d) access to benefits, payroll, human resources (\u201cHR\u201d), and compliance support\u2014all in one place.<\/p>\n

Shares: 7 million<\/p>\n

Price Range: $29.00-$32.00<\/p>\n

Market Cap: $1.8b-$2.0b<\/p>\n

Trade Date:\u00a0 Thursday, 1\/13<\/p>\n

Underwriters: Goldman Sachs, J.P. Morgan, BofA Securities<\/p>\n

Co-Manager(s): Baird, Piper Sandler, Raymond James, Stifel, William Blair, Siebert Williams Shank<\/p>\n

Link to Prospectus: Terms Added: 1-4-22<\/a><\/p>\n

<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW FILINGS Company: Affinia Therapeutics Inc. Symbol: AFTX (Nasdaq) Description:\u00a0 They are a preclinical stage company pioneering a new class of rationally designed gene therapies with potentially curative benefit in patients with both rare and prevalent devastating diseases. Shares: TBD Price Range: TBD Trade Date:\u00a0 TBD Underwriters: Goldman Sachs, Jefferies, Piper Sandler Co-Manager(s): Chardan Link[…]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-23537","post","type-post","status-publish","format-standard","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/23537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=23537"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/23537\/revisions"}],"predecessor-version":[{"id":23538,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/23537\/revisions\/23538"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=23537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=23537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=23537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}